Case Report: Whole-Genome Sequencing of Serially Collected From a Patient With Common Variable Immunodeficiency Reveals Within-Host Evolution of Resistance to Trimethoprim-Sulfamethoxazole and Azithromycin After Prolonged Treatment With These...

Overview

Journal Front Cell Infect Microbiol

Specialties Cell Biology
Infectious Diseases
Microbiology

Date 2022 Jun 20

PMID 35719354

Authors

Paul Christoffer Lindemann

Haima Mylvaganam

Oddvar Oppegaard

Inger Lill Anthonisen

Nermin Zecic

Dagfinn Skaare

Affiliations

Soon will be listed here.

Abstract

We report within-host evolution of antibiotic resistance to trimethoprim-sulfamethoxazole and azithromycin in a nontypeable strain from a patient with common variable immunodeficiency (CVID), who received repeated or prolonged treatment with these antibiotics for recurrent respiratory tract infections. Whole-genome sequencing of three longitudinally collected sputum isolates during the period April 2016 to January 2018 revealed persistence of a strain of sequence type 2386. Reduced susceptibility to trimethoprim-sulfamethoxazole in the first two isolates was associated with mutations in genes encoding dihydrofolate reductase ( and its promotor region, dihydropteroate synthase (), and thymidylate synthase (), while subsequent substitution of a single amino acid in dihydropteroate synthase (G225A) rendered high-level resistance in the third isolate from 2018. Azithromycin co-resistance in this isolate was associated with amino acid substitutions in 50S ribosomal proteins L4 (W59R) and L22 (G91D), possibly aided by a substitution in AcrB (A604E) of the AcrAB efflux pump. All three isolates were resistant to aminopenicillins and cefotaxime due to TEM-1B beta-lactamase and identical alterations in penicillin-binding protein 3. Further resistance development to trimethoprim-sulfamethoxazole and azithromycin resulted in a multidrug-resistant phenotype. Evolution of multidrug resistance due to horizontal gene transfer and/or spontaneous mutations, along with selection of resistant subpopulations is a particular risk in CVID and other patients requiring repeated and prolonged antibiotic treatment or prophylaxis. Such challenging situations call for careful antibiotic stewardship together with supportive and supplementary treatment. We describe the clinical and microbiological course of events in this case report and address the challenges encountered.

Citing Articles

Ecological and evolutionary mechanisms driving within-patient emergence of antimicrobial resistance.

Shepherd M, Fu T, Harrington N, Kottara A, Cagney K, Chalmers J Nat Rev Microbiol. 2024; 22(10):650-665.

PMID: 38689039 DOI: 10.1038/s41579-024-01041-1.

Molecular characterization of multidrug-resistant non-typeable Haemophilus influenzae with high-level resistance to cefuroxime, levofloxacin, and trimethoprim-sulfamethoxazole.

Su P, Cheng W, Ho C BMC Microbiol. 2023; 23(1):178.

PMID: 37407940 PMC: 10320927. DOI: 10.1186/s12866-023-02926-6.

The alginate polymer OligoG alters susceptibility of biofilm-embedded non-typeable to ampicillin and ciprofloxacin.

Marienborg K, Ambur O, Okstad O, Skaare D JAC Antimicrob Resist. 2023; 5(2):dlad046.

PMID: 37082420 PMC: 10111140. DOI: 10.1093/jacamr/dlad046.

Molecular epidemiology and antibiotic resistance profiles of invasive from Norway 2017-2021.

Tonnessen R, Garcia I, Debech N, Lindstrom J, Wester A, Skaare D Front Microbiol. 2022; 13:973257.

PMID: 36106084 PMC: 9467436. DOI: 10.3389/fmicb.2022.973257.

References

Starner T, Shrout J, Parsek M, Appelbaum P, Kim G . Subinhibitory concentrations of azithromycin decrease nontypeable Haemophilus influenzae biofilm formation and Diminish established biofilms. Antimicrob Agents Chemother. 2007; 52(1):137-45. PMC: 2223912. DOI: 10.1128/AAC.00607-07. View

Georgiou M, Munoz R, Roman F, Canton R, Gomez-Lus R, Campos J . Ciprofloxacin-resistant Haemophilus influenzae strains possess mutations in analogous positions of GyrA and ParC. Antimicrob Agents Chemother. 1996; 40(7):1741-4. PMC: 163409. DOI: 10.1128/AAC.40.7.1741. View

Sperlich J, Grimbacher B, Workman S, Haque T, Seneviratne S, Burns S . Respiratory Infections and Antibiotic Usage in Common Variable Immunodeficiency. J Allergy Clin Immunol Pract. 2017; 6(1):159-168.e3. PMC: 7185402. DOI: 10.1016/j.jaip.2017.05.024. View

Achari A, Somers D, Champness J, Bryant P, Rosemond J, Stammers D . Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nat Struct Biol. 1997; 4(6):490-7. DOI: 10.1038/nsb0697-490. View

Clementi C, Murphy T . Non-typeable Haemophilus influenzae invasion and persistence in the human respiratory tract. Front Cell Infect Microbiol. 2012; 1:1. PMC: 3417339. DOI: 10.3389/fcimb.2011.00001. View

Guevara-Hoyer K, Saz-Leal P, Diez-Rivero C, Ochoa-Grullon J, Fernandez-Arquero M, de Diego R . Trained Immunity Based-Vaccines as a Prophylactic Strategy in Common Variable Immunodeficiency. A Proof of Concept Study. Biomedicines. 2020; 8(7). PMC: 7400202. DOI: 10.3390/biomedicines8070203. View

Skaare D, Anthonisen I, Kahlmeter G, Matuschek E, Natas O, Steinbakk M . Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013. Euro Surveill. 2014; 19(49). DOI: 10.2807/1560-7917.es2014.19.49.20986. View

. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 2020; 49(D1):D480-D489. PMC: 7778908. DOI: 10.1093/nar/gkaa1100. View

Gatt Y, Margalit H . Common Adaptive Strategies Underlie Within-Host Evolution of Bacterial Pathogens. Mol Biol Evol. 2020; 38(3):1101-1121. PMC: 7947768. DOI: 10.1093/molbev/msaa278. View

10.

Long H, Miller S, Strauss C, Zhao C, Cheng L, Ye Z . Antibiotic treatment enhances the genome-wide mutation rate of target cells. Proc Natl Acad Sci U S A. 2016; 113(18):E2498-505. PMC: 4983809. DOI: 10.1073/pnas.1601208113. View

11.

Lode H, Borner K, Koeppe P, Schaberg T . Azithromycin--review of key chemical, pharmacokinetic and microbiological features. J Antimicrob Chemother. 1996; 37 Suppl C:1-8. DOI: 10.1093/jac/37.suppl_c.1. View

12.

Vonarburg C, Loetscher M, Spycher M, Kropf A, Illi M, Salmon S . Topical application of nebulized human IgG, IgA and IgAM in the lungs of rats and non-human primates. Respir Res. 2019; 20(1):99. PMC: 6532128. DOI: 10.1186/s12931-019-1057-3. View

13.

Daley D, Rapp M, Granseth E, Melen K, Drew D, von Heijne G . Global topology analysis of the Escherichia coli inner membrane proteome. Science. 2005; 308(5726):1321-3. DOI: 10.1126/science.1109730. View

14.

Garmendia J, Viadas C, Calatayud L, Mell J, Marti-Lliteras P, Euba B . Characterization of nontypable Haemophilus influenzae isolates recovered from adult patients with underlying chronic lung disease reveals genotypic and phenotypic traits associated with persistent infection. PLoS One. 2014; 9(5):e97020. PMC: 4019658. DOI: 10.1371/journal.pone.0097020. View

15.

Izano E, Shah S, Kaplan J . Intercellular adhesion and biocide resistance in nontypeable Haemophilus influenzae biofilms. Microb Pathog. 2009; 46(4):207-13. PMC: 2691864. DOI: 10.1016/j.micpath.2009.01.004. View

16.

Blazquez J, Couce A, Rodriguez-Beltran J, Rodriguez-Rojas A . Antimicrobials as promoters of genetic variation. Curr Opin Microbiol. 2012; 15(5):561-9. DOI: 10.1016/j.mib.2012.07.007. View

17.

Rodriguez-Arce I, Marti S, Euba B, Fernandez-Calvet A, Moleres J, Lopez-Lopez N . Inactivation of the Thymidylate Synthase in Non-typeable Modulates Antibiotic Resistance and Has a Strong Impact on Its Interplay with the Host Airways. Front Cell Infect Microbiol. 2017; 7:266. PMC: 5476696. DOI: 10.3389/fcimb.2017.00266. View

18.

Parnham M, Erakovic Haber V, Giamarellos-Bourboulis E, Perletti G, Verleden G, Vos R . Azithromycin: mechanisms of action and their relevance for clinical applications. Pharmacol Ther. 2014; 143(2):225-45. DOI: 10.1016/j.pharmthera.2014.03.003. View

19.

Polverino E, Goeminne P, McDonnell M, Aliberti S, Marshall S, Loebinger M . European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017; 50(3). DOI: 10.1183/13993003.00629-2017. View

20.

Seyama S, Wajima T, Nakaminami H, Noguchi N . Amino Acid Substitution in the Major Multidrug Efflux Transporter Protein AcrB Contributes to Low Susceptibility to Azithromycin in Haemophilus influenzae. Antimicrob Agents Chemother. 2017; 61(11). PMC: 5655073. DOI: 10.1128/AAC.01337-17. View